suplatast tosilate has been researched along with Dermatitis, Atopic in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 5 (62.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, T; Arisaka, O; Fukuda, H; Ono, M; Yamada, Y; Yoshihara, S | 1 |
| Arisaka, O; Fukuda, H; Yoshihara, S | 1 |
| Aoki, M; Fujimoto, K; Higashi, N; Kawana, S; Niimi, Y; Numano, K; Suzuki, K | 1 |
| Kurokawa, I; Mizutani, H; Murakami, T; Nakanishi, K; Tokime, K; Tsutsui, H; Yamanaka, K | 1 |
| Furue, M; Katayama, I; Miyachi, Y | 1 |
| Kimata, H | 1 |
| Hira, K; Mitsuishi, K; Ogawa, H; Suto, H; Takamori, K; Uchida, T; Unno, T; Yoshiike, T | 1 |
| Koda, A; Matsuura, N; Yanagihara, Y | 1 |
1 review(s) available for suplatast tosilate and Dermatitis, Atopic
| Article | Year |
|---|---|
Suplatast/tacrolimus combination therapy for refractory facial erythema in adult patients with atopic dermatitis: a meta-analysis study.
Topics: Adult; Anti-Allergic Agents; Arylsulfonates; Dermatitis, Atopic; Drug Therapy, Combination; Erythema; Face; Female; Humans; Immunosuppressive Agents; Male; Sulfonium Compounds; Tacrolimus; Treatment Outcome | 2007 |
2 trial(s) available for suplatast tosilate and Dermatitis, Atopic
| Article | Year |
|---|---|
Early intervention with suplatast tosilate for prophylaxis of pediatric atopic asthma: a pilot study.
Topics: Allergens; Animals; Anti-Allergic Agents; Arylsulfonates; Asthma; Chemoprevention; Dermatitis, Atopic; Egg White; Female; Food Hypersensitivity; Humans; Hypersensitivity, Immediate; Incidence; Infant; Ketotifen; Male; Milk; Pilot Projects; Respiratory Sounds; Sulfonium Compounds; Th1 Cells; Th2 Cells; Time Factors; Treatment Outcome | 2009 |
Selective enhancement of production of IgE, IgG4, and Th2-cell cytokine during the rebound phenomenon in atopic dermatitis and prevention by suplatast tosilate.
Topics: Administration, Oral; Administration, Topical; Adolescent; Adult; Anti-Allergic Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibody Formation; Arylsulfonates; Bufexamac; Dermatitis, Atopic; Dexamethasone; Female; Histamine Antagonists; Humans; Immunoglobulin E; Immunoglobulin G; Interleukins; Lymphokines; Male; Substance Withdrawal Syndrome; Sulfonium Compounds; Th2 Cells; Treatment Outcome | 1999 |
5 other study(ies) available for suplatast tosilate and Dermatitis, Atopic
| Article | Year |
|---|---|
Usefulness of suplatast tosilate, a Th2 cytokine inhibitor based on the Th1/Th2 ratio for allergic disease in children: a retrospective study.
Topics: Adolescent; Anti-Allergic Agents; Arylsulfonates; Asthma; Child; Child, Preschool; Cytokines; Dermatitis, Atopic; Drug Therapy, Combination; Eosinophils; Female; Humans; Immunoglobulin E; Infant; Leukocyte Count; Male; Pharmaceutical Solutions; Retrospective Studies; Sulfonium Compounds; Th1-Th2 Balance; Th2 Cells | 2011 |
[The effect of suplatast tosilate on the patients with atopic dermatitis--relationship between clinical symptoms and immunological parameters].
Topics: Adult; Anti-Allergic Agents; Arylsulfonates; Blood Proteins; Dermatitis, Atopic; Eosinophil Granule Proteins; Eosinophils; Female; Humans; Immunoglobulin E; Interleukin-5; L-Lactate Dehydrogenase; Leukocyte Count; Male; Ribonucleases; Sulfonium Compounds; Treatment Outcome | 2003 |
Topical suplatast tosilate (IPD) ameliorates Th2 cytokine-mediated dermatitis in caspase-1 transgenic mice by downregulating interleukin-4 and interleukin-5.
Topics: Administration, Topical; Animals; Anti-Allergic Agents; Arylsulfonates; Caspase 1; Dermatitis, Atopic; Down-Regulation; Histamine; Immunoglobulin E; Interferon-gamma; Interleukin-4; Interleukin-5; Male; Mast Cells; Mice; Mice, Inbred C57BL; Mice, Transgenic; Models, Animal; RNA, Messenger; Skin; Spleen; Sulfonium Compounds; Th2 Cells | 2006 |
[The effect of suplatast tosilate on immunological parameters for the patients with atopic dermatitis].
Topics: Adult; Anti-Allergic Agents; Arylsulfonates; Blood Proteins; Dermatitis, Atopic; Drug Administration Schedule; Eosinophil Granule Proteins; Eosinophils; Female; Humans; Immunoglobulin E; Leukocyte Count; Male; Ribonucleases; Severity of Illness Index; Sulfonium Compounds | 2000 |
IPD-1151T: a prototype drug for IgE antibody synthesis modulation.
Topics: Animals; Antibodies; Antibody Formation; Arylsulfonates; Asthma; B-Lymphocytes; Dermatitis, Atopic; Female; Hypersensitivity; Immunoglobulin E; Interleukin-4; Mice; Mice, Inbred BALB C; Receptors, Fc; Sulfonium Compounds | 1991 |